IP Library Granted Patent US 7,783,336
Granted Patent B2
US 7,783,336 · App. 10/856,489 · Granted Aug 24, 2010

Subcutaneous biopsy cavity marker device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,783,336
App. No.
10/856,489
Granted
Aug 24, 2010
Kind
B2
Abstract

A marking device for identifying a subcutaneous biopsy cavity having a first nonabsorbable marker element detectable by a first imaging modality and a second nonabsorbable marker element detectable by a second imaging modality but not detectable by the first imaging modality.

Claims (26)

1. A marking device for identifying a subcutaneous biopsy cavity comprising:

a first nonabsorbable marker element detectable by a first imaging modality, which is a radiographic imaging modality; and

a second nonabsorbable marker element detectable by a second imaging modality, which is ultrasonography, but not detectable by said first imaging modality,

wherein the second marker element extends generally along an axis and the first marker element is radiopaque, encircles a portion of the second marker element, and lies in a plane that is generally perpendicular to the axis of the second marker element.

2. The marking device of claim 1 wherein said device is nonpalpable.

3. The marking device of claim 1 wherein said first marker element comprises a material selected from a group consisting of gold; iridium; nickel; rhodium; silver; stainless steel; tantalum; titanium; and alloys thereof.

4. The marking device of claim 1 wherein said first marker element comprises titanium.

5. The marking device of claim 1 wherein said first marker element comprises a radiopaque additive.

6. The marking device of claim 5 wherein said radiopaque additive is selected from the group consisting of barium-containing compounds, bismuth-containing compounds, powdered tantalum, powdered tungsten, barium carbonate, bismuth oxide, and barium sulfate.

7. The marking device of claim 1 wherein said first marker element is ring-shaped.

8. The marking device of claim 1 wherein said radiographic imaging modality is an x-ray.

9. The marking device of claim 8 wherein said x-ray is a mammogram.

10. The marking device of claim 1 wherein said first imaging modality is mammography.

11. The marking device of claim 1 wherein said second marker element comprises a material selected from the group consisting of fluoropolymers, polyester and polyester mixtures, polypropylene, and nylon and nylon mixtures.

12. The marking device of claim 1 wherein said second marker element comprises an echogenic coating.

13. The marking device of claim 1 wherein said second marker element comprises a knotted suture.

14. The marking device of claim 1 wherein said second marker element comprises a looped arrangement of suture.

15. The marking device of claim 1 wherein said second marker element comprises a layered arrangement of sheet or mesh-like material.

16. The marking device of claim 1 wherein said second marker element has a rolled configuration.

17. The marking device of claim 1 wherein said second marker element has a geometry distinguishable from an anatomically occurring artifact or tissue pathology.

18. The marking device of claim 1 wherein said second nonabsorbable marker element is resilient.

19. The marking device of claim 1 wherein said first marker element comprises a metal and said second nonabsorbable marker element comprises a polymer.

20. A method of identifying a subcutaneous biopsy cavity comprising:

placing a biopsy cavity marking device into said biopsy cavity, the biopsy cavity marking device having a first nonabsorbable marker element and a second nonabsorbable marker element, wherein the second marker element extends generally along an axis and the first marker element is radiopaque, encircles a portion of the second marker element, and lies in a plane that is generally perpendicular to the axis of the second marker element;

detecting said first marker using a first imaging modality, which is a radiographic imaging modality; and

detecting said second marker element by a second imaging modality, which is ultrasonography, that differs from said first imaging modality, and said second marker element being undetectable by said first imaging modality, wherein said biopsy cavity marking device is nonpalpable.

Assignments (2)
SECURITY AGREEMENT Recorded Jul 13, 2010
From: DEVICOR MEDICAL PRODUCTS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 024672/0088 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2010
From: ETHICON ENDO-SURGERY, INC.
To: DEVICOR MEDICAL PRODUCTS, INC.
Reel/Frame 024656/0606 →